K-numberK250381
Device nameDeepsight NeedleVue LC1 Ultrasound System
ApplicantDeepSight Technology, Inc.
Product codeIYO
Device classClass II
Decision dateAug 1, 2025
DecisionSubstantially Equivalent
Regulation892.1560
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The DeepSight NeedleVue LC1 Ultrasound System is a general-purpose diagnostic ultrasound device mounted on a movable cart for imaging adult and pediatric patients. It is intended for abdominal, pediatric, small organ, peripheral vascular, fetal, urological, and musculoskeletal conventional and superficial imaging by qualified healthcare professionals in hospitals, clinics, and other medical settings.

Technological characteristics

The device includes three functional blocks: a front end with a single curved array transducer and analog signal processing; a back end with touchscreen interface, memory, USB export, and LCD display; and power systems. It operates in 2D B-mode with harmonic imaging capability, uses 120 VAC power, and features beamforming on both transmit and receive sides with digital reconstruction and processing.

Test standards cited

IEC 62304 (software lifecycle), IEC 60601-1-2 (EMC), IEC 60601-1 (general safety), IEC 60601-2-37 (ultrasound safety), IEC 62359 (thermal and mechanical indices), IEC 62127-1 and 62127-2 (hydrophones and acoustic field measurement). FDA guidance documents on diagnostic ultrasound, device software, EMC, cybersecurity, and reprocessing were also cited.

Substantial equivalence argument

The subject device and predicate (GE LOGIQ E9) are both general-purpose diagnostic ultrasound systems with identical intended uses and substantially equivalent indications. Both operate on the same three functional principles (front end, back end, power systems), use the same power source, and employ identical beamforming and processing architectures. Although the predicate supports more imaging modes and transducer types, these differences do not raise different safety or effectiveness questions and do not introduce new functionalities. Performance testing demonstrates comparable safety and effectiveness profiles between the two systems.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →